Stephenson Harwood’s Life Sciences & Healthcare team partnered with BiotechTV to discuss the key trends affecting investments into life sciences...
sciences
RS RSM Canada More RSM empowers middle market companies worldwide to take charge of change....
This article is part of Bain's 2025 M&A Report. Once the frontrunners of M&A activity, healthcare...
2024 has been a landmark year for innovation at the crossroads of health and technology. As AWS re:Invent 2024 approaches,...
Amount B is intended to simplify transfer pricing rules relating to distribution activities, thus reducing cost and administrative load, and...
